EV/EBITDA
-0.08
-0.01-14.29%
5 min ago
Summary
- As of February 26, 2025, RLMD EV/EBITDA is -0.08, with a fall of -0.01 (-14.29%) during the most recent trading day.
- Over the past year, RLMD EV/EBITDA has increased by +1.62 (+95.29%).
- RLMD EV/EBITDA is now -100.26% below its all-time high of 30.48.
Performance
RLMD EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RLMD EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -14.3% | +3.1% | +2.6% |
1 m1 month | +27.3% | -30.9% | -26.9% |
3 m3 months | +90.9% | -91.4% | -89.7% |
6 m6 months | +91.1% | -91.5% | -90.0% |
ytdytd | +46.7% | -49.9% | -45.1% |
1 y1 year | +95.3% | -96.1% | -95.3% |
5 y5 years | +99.9% | -99.0% | -99.4% |
RLMD EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -14.3% | -0.11 | +27.3% | |
3 m | 3-month | -0.07 | -14.3% | -1.12 | +92.9% |
6 m | 6-month | -0.07 | -14.3% | -1.22 | +93.4% |
1 y | 1-year | -0.07 | -14.3% | -1.96 | +95.9% |
3 y | 3-year | -0.07 | -14.3% | -6.49 | +98.8% |
5 y | 5-year | -0.07 | -14.3% | -71.42 | +99.9% |
alltime | all time | 30.48 | -100.3% | -2629 | +100.0% |
Relmada Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -0.08(-46.7%) |
2024 | -0.15(-87.4%) |
2023 | -1.19(+91.9%) |
2022 | -0.62(-86.6%) |
2021 | -4.62(-46.1%) |
2020 | -8.57(-84.3%) |
Date | Value |
---|---|
2019 | -54.58(+1731.5%) |
2018 | -2.98(+297.3%) |
2017 | -0.75(-21.9%) |
2016 | -0.96(-35.6%) |
2015 | -1.49(-73.1%) |
2014 | -5.54 |
FAQ
- What is Relmada Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Relmada Therapeutics?
- What is RLMD EV/EBITDA year-to-date change?
- What is Relmada Therapeutics EV/EBITDA year-on-year change?
What is Relmada Therapeutics EV/EBITDA?
The current EV/EBITDA of RLMD is -0.08
What is the all time high EV/EBITDA for Relmada Therapeutics?
Relmada Therapeutics all-time high EV/EBITDA is 30.48
What is RLMD EV/EBITDA year-to-date change?
Relmada Therapeutics EV/EBITDA has changed by +0.07 (+46.67%) since the beginning of the year
What is Relmada Therapeutics EV/EBITDA year-on-year change?
Over the past year, RLMD EV/EBITDA has changed by +1.62 (+95.29%)